Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Valvular Heart Disease

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 159 articles:
HTML format



Single Articles


    May 2020
  1. STROM JB, Faridi KF, Butala NM, Zhao Y, et al
    Use of Administrative Claims to Assess Outcomes and Treatment Effect in Randomized Clinical Trials for Transcatheter Aortic Valve Replacement: Findings from the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND
    Circulation. 2020 May 21. doi: 10.1161/CIRCULATIONAHA.120.046159.
    PubMed     Abstract available


  2. DELGADO V, Kumbhani DJ
    Cardiac and Vascular Changes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Aortic Stenosis.
    Circulation. 2020;141:1538-1540.
    PubMed    


    April 2020
  3. PIBAROT P, Salaun E, Dahou A, Avenatti E, et al
    Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial.
    Circulation. 2020 Apr 10. doi: 10.1161/CIRCULATIONAHA.119.044574.
    PubMed     Abstract available


  4. LI S, Nguyen NUN, Xiao F, Menendez-Montes I, et al
    Mechanism of Eccentric Cardiomyocyte Hypertrophy Secondary to Severe Mitral Regurgitation.
    Circulation. 2020 Apr 10. doi: 10.1161/CIRCULATIONAHA.119.043939.
    PubMed     Abstract available


    March 2020
  5. YADGIR S, Johnson CO, Aboyans V, Adebayo OM, et al
    Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.119.043391.
    PubMed     Abstract available


    February 2020
  6. HALIM SA, Edwards FH, Dai D, Li Z, et al
    Outcomes of Transcatheter Aortic Valve Replacement in Patients with Bicuspid Aortic Valve Disease: A Report from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
    Circulation. 2020 Feb 26. doi: 10.1161/CIRCULATIONAHA.119.040333.
    PubMed     Abstract available


    January 2020
  7. LUETKENS JA, Faron A, Geissler HL, Al-Kassou B, et al
    Opportunistic Computed Tomography Imaging for the Assessment of Fatty Muscle Fraction Predicts Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Circulation. 2020;141:234-236.
    PubMed    



  8. Correction to: Slower Progress of Aortic Valve Calcification With Vitamin K Supplementation: Results From a Prospective Interventional Proof-of-Concept Study.
    Circulation. 2020;141:e54.
    PubMed    


  9. FAYSSOIL A
    Letter by Fayssoil Regarding Article, "Excess Mortality Associated With Functional Tricuspid Regurgitation Complicating Heart Failure With Reduced Ejection Fraction".
    Circulation. 2020;141:e1-e2.
    PubMed    


    December 2019
  10. KITKUNGVAN D, Yang EY, El Tallawi KC, Nagueh SF, et al
    Prognostic Implications of Diffuse Interstitial Fibrosis in Asymptomatic Primary Mitral Regurgitation.
    Circulation. 2019;140:2122-2124.
    PubMed    


    November 2019
  11. SLOSTAD BD, Witt CM, O'Leary PW, Maleszewski JJ, et al
    Unicuspid Aortic Valve: Demographics, Comorbidities, Echocardiographic Features, and Long-Term Outcomes.
    Circulation. 2019;140:1853-1855.
    PubMed    


  12. VAN BELLE E, Vincent F, Labreuche J, Auffret V, et al
    Balloon-Expandable versus Self-Expanding Transcatheter Aortic Valve Replacement: A Propensity-Matched Comparison from The France-TAVI Registry.
    Circulation. 2019 Nov 16. doi: 10.1161/CIRCULATIONAHA.119.043785.
    PubMed     Abstract available


  13. DEHARO P, Bisson A, Herbert J, Lacour T, et al
    Impact of Sapien 3 Balloon-Expandable Versus Evolut R Self-Expandable Transcatheter Aortic Valve Implantation in Patients with Aortic Stenosis: Data from a Nationwide Analysis.
    Circulation. 2019 Nov 16. doi: 10.1161/CIRCULATIONAHA.119.043971.
    PubMed     Abstract available


    October 2019
  14. KANEKO T
    Killing Two Birds With One Stone: Complete Percutaneous Approach to Aortic Valve Replacement and Revascularization.
    Circulation. 2019;140:1306-1307.
    PubMed    


  15. KATO N, Padang R, Pislaru C, Miranda WR, et al
    Hemodynamics and Prognostic Impact of Concomitant Mitral Stenosis in Patients Undergoing Surgical or Transcatheter Aortic Valve Replacement for Aortic Stenosis.
    Circulation. 2019;140:1251-1260.
    PubMed     Abstract available


  16. DONNELLAN E, Alashi A, Johnston DR, Gillinov AM, et al
    Outcomes of Patients With Mediastinal Radiation-Associated Mitral Valve Disease Undergoing Cardiac Surgery.
    Circulation. 2019;140:1288-1290.
    PubMed    


    September 2019
  17. BONOW RO, Mark DB, O'Gara PT
    Coapting Cost and Clinical Outcomes in Transcatheter Intervention for Secondary Mitral Regurgitation.
    Circulation. 2019 Sep 29. doi: 10.1161/CIRCULATIONAHA.119.043408.
    PubMed    


  18. BARON SJ, Wang K, Arnold SV, Magnuson EA, et al
    Cost-Effectiveness of Transcatheter Mitral Valve Repair versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation: Results from the COAPT Trial.
    Circulation. 2019 Sep 29. doi: 10.1161/CIRCULATIONAHA.119.043275.
    PubMed     Abstract available


  19. DESAI MY, Svensson LG
    Chronic Severe Aortic Regurgitation: Should We Lower Operating Thresholds?
    Circulation. 2019;140:1045-1047.
    PubMed    


  20. IUNG B, Delgado V, Rosenhek R, Price S, et al
    Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
    Circulation. 2019 Sep 12. doi: 10.1161/CIRCULATIONAHA.119.041080.
    PubMed     Abstract available


  21. BASSO C, Iliceto S, Thiene G, Perazzolo Marra M, et al
    Mitral Valve Prolapse, Ventricular Arrhythmias, and Sudden Death.
    Circulation. 2019;140:952-964.
    PubMed     Abstract available


  22. KUNDI H, Faridi KF, Wang Y, Wadhera RK, et al
    Geographic Patterns of Growth for Transcatheter Aortic Valve Replacement in the United States.
    Circulation. 2019;140:969-971.
    PubMed    


  23. TANG GHL, Verma S, Bhatt DL
    Transcatheter Aortic Valve Replacement in Low-Risk Patients.
    Circulation. 2019;140:801-803.
    PubMed    


  24. SONDERGAARD L, Popma JJ, Reardon MJ, Van Mieghem NM, et al
    Comparison of a Complete Percutaneous versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results from the Randomized SURTAVI Trial.
    Circulation. 2019 Sep 3. doi: 10.1161/CIRCULATIONAHA.118.039564.
    PubMed     Abstract available


    August 2019
  25. FULMER D, Toomer K, Guo L, Moore K, et al
    Defects in the Exocyst-Cilia Machinery Cause Bicuspid Aortic Valve Disease and Aortic Stenosis.
    Circulation. 2019 Aug 7. doi: 10.1161/CIRCULATIONAHA.119.038376.
    PubMed     Abstract available


    July 2019
  26. AILAWADI G, Lim DS, Grayburn PA
    Response by Ailawadi et al to Letter Regarding Article, "One-Year Outcomes After MitraClip for Functional Mitral Regurgitation".
    Circulation. 2019;140:e175-e176.
    PubMed    


  27. GUL EE, Haseeb S
    Letter by Gul and Haseeb Regarding Article, "One-Year Outcomes After MitraClip for Functional Mitral Regurgitation".
    Circulation. 2019;140:e173-e174.
    PubMed    


  28. MITAL S, Ommen S
    To Screen or Not to Screen, That Is the Question.
    Circulation. 2019;140:193-195.
    PubMed    


  29. SIGWART U
    Therapeutic Myocardial Infarction for Hypertrophic Obstructive Cardiomyopathy: Is It Appropriate?
    Circulation. 2019;140:11-12.
    PubMed    


    June 2019
  30. DIETZ MF, Prihadi EA, van der Bijl P, Goedemans L, et al
    Prognostic Implications of Right Ventricular Remodeling and Function in Patients with Significant Secondary Tricuspid Regurgitation.
    Circulation. 2019 Jun 12. doi: 10.1161/CIRCULATIONAHA.119.039630.
    PubMed     Abstract available


  31. PRENDERGAST BD, Redwood SR
    Transcatheter Aortic Valve Replacement.
    Circulation. 2019;139:2724-2727.
    PubMed    


  32. MIRTSCHINK P, Bischof C, Pham MD, Sharma R, et al
    Inhibition of the Hypoxia-Inducible Factor 1alpha-Induced Cardiospecific HERNA1 Enhance-Templated RNA Protects From Heart Disease.
    Circulation. 2019;139:2778-2792.
    PubMed     Abstract available


  33. GUALA A, Rodriguez-Palomares J, Galian-Gay L, Teixido-Tura G, et al
    Partial Aortic Valve Leaflet Fusion Is Related to Deleterious Alteration of Proximal Aorta Hemodynamics.
    Circulation. 2019;139:2707-2709.
    PubMed    


  34. FREITAS-FERRAZ AB, Tirado-Conte G, Dagenais F, Ruel M, et al
    Aortic Stenosis and Small Aortic Annulus.
    Circulation. 2019;139:2685-2702.
    PubMed     Abstract available


    May 2019
  35. BENFARI G, Antoine C, Miller WL, Thapa P, et al
    Excess Mortality Associated with Functional Tricuspid Regurgitation Complicating Heart Failure with Reduced Ejection Fraction.
    Circulation. 2019 May 23. doi: 10.1161/CIRCULATIONAHA.118.038946.
    PubMed     Abstract available


  36. ENRIQUEZ-SARANO M, Michelena HI, Grigioni F
    Treatment of Functional Mitral Regurgitation.
    Circulation. 2019;139:2289-2291.
    PubMed    


  37. SMITH GL, Eisner DA
    Calcium Buffering in the Heart in Health and Disease.
    Circulation. 2019;139:2358-2371.
    PubMed     Abstract available


  38. REDDY YNV, Nishimura RA
    Paradox of Low-Gradient Aortic Stenosis.
    Circulation. 2019;139:2195-2197.
    PubMed    


  39. PACKER M, Grayburn PA
    Contrasting Effects of Pharmacological, Procedural and Surgical Interventions on Proportionate and Disproportionate Functional Mitral Regurgitation in Chronic Heart Failure.
    Circulation. 2019 May 1. doi: 10.1161/CIRCULATIONAHA.119.039612.
    PubMed     Abstract available


    March 2019
  40. MARON BJ, Rowin EJ, Maron MS
    Letter by Maron et al Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)".
    Circulation. 2019;139:1557-1558.
    PubMed    


  41. HO CY, Day SM, Ashley EA, Michels M, et al
    Response by Ho et al to Letter Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)".
    Circulation. 2019;139:1559-1560.
    PubMed    


  42. LEHMAN SJ, Tal-Grinspan L, Lynn ML, Strom J, et al
    Chronic Calmodulin-Kinase II Activation Drives Disease Progression in Mutation-Specific Hypertrophic Cardiomyopathy.
    Circulation. 2019;139:1517-1529.
    PubMed     Abstract available


  43. ENRIQUEZ-SARANO M, Antoine C
    Response by Enriquez-Sarano and Antoine to Letter Regarding Article, "Clinical Outcome of Degenerative Mitral Regurgitation: Critical Importance of Echocardiographic Quantitative Assessment in Routine Practice".
    Circulation. 2019;139:1465-1466.
    PubMed    


  44. PAL N
    Letter by Pal Regarding Article, "Clinical Outcome of Degenerative Mitral Regurgitation: Critical Importance of Echocardiographic Quantitative Assessment in Routine Practice".
    Circulation. 2019;139:1463-1464.
    PubMed    


  45. MULLENS W, Martens P
    Sacubitril/Valsartan to Reduce Secondary Mitral Regurgitation.
    Circulation. 2019;139:1366-1370.
    PubMed    


    February 2019
  46. SALEEB SF, Gauvreau K, Mayer JE, Newburger JW, et al
    Aortic Valve Replacement With Bovine Pericardial Tissue Valve in Children and Young Adults.
    Circulation. 2019;139:983-985.
    PubMed    


  47. CARRIER L
    Making Sense of Inhibiting Nonsense in Hypertrophic Cardiomyopathy.
    Circulation. 2019;139:812-814.
    PubMed    


  48. UDELSON JE
    Evaluating and Reducing the Risk of Sudden Death in Hypertrophic Cardiomyopathy.
    Circulation. 2019;139:727-729.
    PubMed    


  49. MAURIZI N, Michels M, Rowin EJ, Semsarian C, et al
    Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy.
    Circulation. 2019;139:830-833.
    PubMed    


  50. SEEGER T, Shrestha R, Lam CK, Chen C, et al
    A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay.
    Circulation. 2019;139:799-811.
    PubMed     Abstract available


  51. LEE DP, Tan WLW, Anene-Nzelu CG, Lee CJM, et al
    A Robust CTCF-Based Chromatin Architecture Underpins Epigenetic Changes in the Heart Failure Stress-Gene Response.
    Circulation. 2019 Feb 5. doi: 10.1161/CIRCULATIONAHA.118.036726.
    PubMed     Abstract available


  52. THYREGOD HGH, Ihlemann N, Jorgensen TH, Nissen H, et al
    Five-Year Clinical and Echocardiographic Outcomes from the Nordic Aortic Valve Intervention (NOTION) Randomized Clinical Trial in Lower Surgical Risk Patients.
    Circulation. 2019 Feb 1. doi: 10.1161/CIRCULATIONAHA.118.036606.
    PubMed     Abstract available


    January 2019
  53. BAUMGARTNER H
    Has the Time Come to Recommend Percutaneous Mitral Edge-to-Edge Repair for Severe Secondary Mitral Regurgitation?
    Circulation. 2019;139:48-50.
    PubMed    


  54. AILAWADI G, Lim DS, Mack MJ, Trento A, et al
    One-Year Outcomes After MitraClip for Functional Mitral Regurgitation.
    Circulation. 2019;139:37-47.
    PubMed     Abstract available


    December 2018
  55. KANG DH, Park SJ, Shin SH, Hong GR, et al
    Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation: The PRIME Study.
    Circulation. 2018 Dec 5. doi: 10.1161/CIRCULATIONAHA.118.037077.
    PubMed     Abstract available


  56. ASGAR AW
    Transcatheter Aortic Valve Replacement and Valve Durability.
    Circulation. 2018;138:2608-2610.
    PubMed    


  57. FIORILLI PN, Giri J
    Should Transcatheter Aortic Valve Replacement Be the Procedure of Choice for Intermediate-Risk Patients With Severe Aortic Stenosis?
    Circulation. 2018;138:2624-2626.
    PubMed    


  58. DIDIER R, Eltchaninoff H, Donzeau-Gouge P, Chevreul K, et al
    Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients.
    Circulation. 2018;138:2597-2607.
    PubMed     Abstract available


  59. WERNER N, Zahn R, Beckmann A, Bauer T, et al
    Patients at Intermediate Surgical Risk Undergoing Isolated Interventional or Surgical Aortic Valve Implantation for Severe Symptomatic Aortic Valve Stenosis.
    Circulation. 2018;138:2611-2623.
    PubMed     Abstract available


    November 2018
  60. BARON SJ, Wang K, House JA, Magnuson EA, et al
    Cost-Effectiveness of Transcatheter vs. Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis at Intermediate Risk:Results from the PARTNER 2 Trial.
    Circulation. 2018 Nov 29. doi: 10.1161/CIRCULATIONAHA.118.035236.
    PubMed     Abstract available


    October 2018
  61. YAGISHITA A, Goya M, Hirao K
    Simultaneous Recording of the P Wave During Atrial Fibrillation.
    Circulation. 2018;138:2057-2060.
    PubMed    


  62. VAKAMUDI S, Jellis C, Mick S, Wu Y, et al
    Sex Differences in the Etiology of Surgical Mitral Valve Disease.
    Circulation. 2018;138:1749-1751.
    PubMed    


  63. DONNELLAN E, Krishnaswamy A, Hutt-Centeno E, Johnston DR, et al
    Outcomes of Patients With Mediastinal Radiation-Associated Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.
    Circulation. 2018;138:1752-1754.
    PubMed    


  64. SPIEWAK M
    Letter by Spiewak Regarding Article, "Prognostic Implications of Magnetic Resonance-Derived Quantification in Asymptomatic Patients With Organic Mitral Regurgitation: Comparison With Doppler Echocardiography-Derived Integrative Approach".
    Circulation. 2018;138:1608-1609.
    PubMed    


  65. PENICKA M
    Response by Penicka to Letter Regarding Article, "Prognostic Implications of Magnetic Resonance-Derived Quantification in Asymptomatic Patients With Organic Mitral Regurgitation: Comparison With Doppler Echocardiography-Derived Integrative Approach".
    Circulation. 2018;138:1610-1611.
    PubMed    


    September 2018
  66. URETSKY S, Gillam LD
    Revisiting and Confirming the Prognostic Importance of Effective Regurgitant Orifice Area in Degenerative Mitral Regurgitation.
    Circulation. 2018;138:1327-1329.
    PubMed    


  67. GILLAM LD, Koulogiannis KP, Marcoff L
    Bioprosthetic Aortic Valve Deterioration.
    Circulation. 2018;138:986-988.
    PubMed    


  68. HOURDAIN J, Clavel MA, Deharo JC, Asirvatham S, et al
    Common Phenotype in Patients With Mitral Valve Prolapse Who Experienced Sudden Cardiac Death.
    Circulation. 2018;138:1067-1069.
    PubMed    


  69. SALAUN E, Mahjoub H, Girerd N, Dagenais F, et al
    Rate, Timing, Correlates, and Outcomes of Hemodynamic Valve Deterioration After Bioprosthetic Surgical Aortic Valve Replacement.
    Circulation. 2018;138:971-985.
    PubMed     Abstract available


    August 2018
  70. COLLI A, Manzan E, Besola L, Bizzotto E, et al
    One-Year Outcomes After Transapical Echocardiography-Guided Mitral Valve Repair.
    Circulation. 2018;138:843-845.
    PubMed    



  71. Correction to: Myeloid Cells Remodel the Mitral Valve.
    Circulation. 2018;138:e125.
    PubMed    


    July 2018
  72. GOMES AV
    Spatiotemporal Multi-Omics-Derived Atlas of Calcific Aortic Valve Disease.
    Circulation. 2018;138:394-396.
    PubMed    


  73. MUSA TA, Treibel TA, Vassiliou VS, Captur G, et al
    Myocardial Scar and Mortality in Severe Aortic Stenosis: Data from the BSCMR Valve Consortium.
    Circulation. 2018 Jul 12. pii: CIRCULATIONAHA.117.032839.
    PubMed     Abstract available


  74. SORAJJA P, Ailawadi G
    Argument for Prophylactic, Catheter-Based Repair of Mitral Regurgitation.
    Circulation. 2018;138:125-127.
    PubMed    


  75. GOLDFARB M, Lauck S, Webb JG, Asgar AW, et al
    Malnutrition and Mortality in Frail and Non-Frail Older Adults Undergoing Aortic Valve Replacement.
    Circulation. 2018 Jul 5. pii: CIRCULATIONAHA.118.033887.
    PubMed     Abstract available


    June 2018
  76. GARCIA-GARCIA HM, McFadden EP, Farb A, Mehran R, et al
    Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.
    Circulation. 2018;137:2635-2650.
    PubMed     Abstract available


  77. HYMAN MC, Patel PA, Giri J
    Response by Hyman et al to Letter Regarding Article, "Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights From the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Car
    Circulation. 2018;137:2545-2546.
    PubMed    


  78. SNIECINSKI RM, Mackensen GB, Kertai MD
    Letter by Sniecinski et al Regarding Article, "Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the National Cardiovascular Data Registry Society of Thoracic Surgeons/American College of Cardiology
    Circulation. 2018;137:2543-2544.
    PubMed    


  79. CREMER S, Nahrendorf M
    Myeloid Cells Remodel the Mitral Valve.
    Circulation. 2018;137:2494-2496.
    PubMed    


  80. ROWIN EJ, Maron MS, Maron BJ
    Response by Rowin et al to Letter Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".
    Circulation. 2018;137:2541-2542.
    PubMed    


  81. WANG L, Zhao YT
    Letter by Wang and Zhao Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".
    Circulation. 2018;137:2540.
    PubMed    


  82. ZHANG L, Xu XM
    Letter by Zhang and Xu Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".
    Circulation. 2018;137:2539.
    PubMed    


    May 2018
  83. ANTOINE C, Benfari G, Michelena HI, Malouf JF, et al
    Clinical Outcome of Degenerative Mitral Regurgitation: Critical Importance of Echocardiographic Quantitative Assessment in Routine Practice.
    Circulation. 2018 May 31. pii: CIRCULATIONAHA.117.033173.
    PubMed     Abstract available


  84. HENG EL, Diller GP, Gatzoulis MA, Babu-Narayan SV, et al
    Response by Heng et al to Letter Regarding Article, "Immediate and Midterm Cardiac Remodeling After Surgical Pulmonary Valve Replacement in Adults With Repaired Tetralogy of Fallot: A Prospective Cardiovascular Magnetic Resonance and Clinical Study".
    Circulation. 2018;137:2186-2187.
    PubMed    


  85. ROMEO JLR, Bogers AJJC, Mokhles MM
    Letter by Romeo et al Regarding Article, "Immediate and Midterm Cardiac Remodeling After Surgical Pulmonary Valve Replacement in Adults With Repaired Tetralogy of Fallot: A Prospective Cardiovascular Magnetic Resonance and Clinical Study".
    Circulation. 2018;137:2184-2185.
    PubMed    


  86. CASELLI S, Mango F, Clark J, Pandian NG, et al
    Prevalence and Clinical Outcome of Athletes With Mitral Valve Prolapse.
    Circulation. 2018;137:2080-2082.
    PubMed    


    April 2018
  87. BRAUNWALD E
    Aortic Stenosis: Then and Now.
    Circulation. 2018 Apr 12. pii: CIRCULATIONAHA.118.033408.
    PubMed     Abstract available


    March 2018
  88. SCHLOTTER F, Halu A, Goto S, Blaser MC, et al
    Spatiotemporal Multi-omics Mapping Generates a Molecular Atlas of the Aortic Valve and Reveals Networks Driving Disease.
    Circulation. 2018 Mar 27. pii: CIRCULATIONAHA.117.032291.
    PubMed     Abstract available


  89. DELGADO V, Hundley WG
    Added Value of Cardiovascular Magnetic Resonance in Primary Mitral Regurgitation.
    Circulation. 2018;137:1361-1363.
    PubMed    


  90. GHARIBEH L, Komati H, Bosse Y, Boodhwani M, et al
    GATA6 Regulates Aortic Valve Remodeling and its Haploinsufficiency Leads to RL-Type Bicuspid Aortic Valve.
    Circulation. 2018 Mar 22. pii: CIRCULATIONAHA.117.029506.
    PubMed     Abstract available


  91. ZAUNER CA, Holshouser JW, Littmann L
    Ventricular Tachycardia and Electrocardiographic ST-Segment-Elevation Myocardial Infarction Without Coronary Artery Disease.
    Circulation. 2018;137:1287-1289.
    PubMed    


  92. ASCH FM, Vannan MA, Singh S, Khandheria B, et al
    Hemodynamic and Echocardiographic Comparison of the Lotus and CoreValve Transcatheter Aortic Valves in Patients With High and Extreme Surgical Risk: An Analysis From the REPRISE III Randomized Controlled Trial (Repositionable Percutaneous Replacement
    Circulation. 2018 Mar 12. pii: CIRCULATIONAHA.118.034129.
    PubMed     Abstract available


  93. ELBAZ-GREENER G, Masih S, Fang J, Ko DT, et al
    Temporal Trends and Clinical Consequences of Wait-Times for Trans-Catheter Aortic Valve Replacement: A Population Based Study.
    Circulation. 2018 Mar 6. pii: CIRCULATIONAHA.117.033432.
    PubMed     Abstract available


  94. HO CY, Link MS
    Predicting the Future in Hypertrophic Cardiomyopathy.
    Circulation. 2018;137:1024-1026.
    PubMed    


    February 2018
  95. LJUNGBERG J, Janiec M, Bergdahl IA, Holmgren A, et al
    Proteomic Biomarkers for Incident Aortic Stenosis Requiring Valvular Replacement.
    Circulation. 2018 Feb 27. pii: CIRCULATIONAHA.117.030414.
    PubMed     Abstract available


  96. VAN HAGEN IM, Thorne SA, Taha N, Youssef G, et al
    Pregnancy Outcomes in Women With Rheumatic Mitral Valve Disease: Results From the Registry of Pregnancy and Cardiac Disease.
    Circulation. 2018;137:806-816.
    PubMed     Abstract available


  97. FRENCH KA, Poppas A
    Rheumatic Heart Disease in Pregnancy: Global Challenges and Clear Opportunities.
    Circulation. 2018;137:817-819.
    PubMed    


  98. FRIEDMAN DJ, Parzynski CS, Heist EK, Russo AM, et al
    Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: A Report from the National Cardiovascular Data Registry.
    Circulation. 2018 Feb 20. pii: CIRCULATIONAHA.117.032167.
    PubMed     Abstract available


    January 2018
  99. PELLICCIA A, Lemme E, Maestrini V, Di Paolo FM, et al
    Does Sport Participation Worsen the Clinical Course of Hypertrophic Cardiomyopathy? Clinical Outcome of Hypertrophic Cardiomyopathy in Athletes.
    Circulation. 2018;137:531-533.
    PubMed    


  100. SABERI S, Day SM
    Exercise and Hypertrophic Cardiomyopathy: Time for a Change of Heart.
    Circulation. 2018;137:419-421.
    PubMed    


  101. DVIR D, Bourguignon T, Otto CM, Hahn RT, et al
    Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves.
    Circulation. 2018;137:388-399.
    PubMed     Abstract available


  102. GLASER N, Jackson V, Holzmann MJ, Franco-Cereceda A, et al
    Response by Glaser et al to Letter Regarding Article, "Prosthetic Valve Endocarditis After Surgical Aortic Valve Replacement".
    Circulation. 2018;137:312-313.
    PubMed    


  103. MADIAS JE
    Letter by Madias Regarding Article, "Prosthetic Valve Endocarditis After Surgical Aortic Valve Replacement".
    Circulation. 2018;137:310-311.
    PubMed    


  104. LEE JKT, Franzone A, Lanz J, Siontis GCM, et al
    Early Detection of Subclinical Myocardial Damage in Chronic Aortic Regurgitation and Strategies for Timely Treatment of Asymptomatic Patients.
    Circulation. 2018;137:184-196.
    PubMed     Abstract available


    December 2017
  105. PENICKA M, Vecera J, Mirica DC, Kotrc M, et al
    Prognostic Implications of Magnetic Resonance - Derived Quantification in Asymptomatic Patients with Organic Mitral Regurgitation: Comparison with Doppler Echocardiography-Derived Integrative Approach.
    Circulation. 2017 Dec 21. pii: CIRCULATIONAHA.117.029332.
    PubMed     Abstract available


  106. SPIRITO P
    Atrial Fibrillation in Hypertrophic Cardiomyopathy: New Light on an Old Problem.
    Circulation. 2017;136:2437-2439.
    PubMed    


    November 2017
  107. BROWN CH 4TH, Hasan RK, Brady MB
    Is Less Really More? Conscious Sedation or General Anesthesia for Transcatheter Aortic Valve Replacement.
    Circulation. 2017;136:2141-2143.
    PubMed    


  108. ROCHA RV, Manlhiot C, Feindel CM, Yau TM, et al
    Surgical Enlargement of the Aortic Root Does Not Increase the Operative Risk of Aortic Valve Replacement.
    Circulation. 2017 Nov 22. pii: CIRCULATIONAHA.117.030525.
    PubMed     Abstract available


  109. YAMAMOTO M, Shimura T, Hayashida K
    Response by Yamamoto et al to Letter Regarding Article, "Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement".
    Circulation. 2017;136:1987-1988.
    PubMed    


  110. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement".
    Circulation. 2017;136:1985-1986.
    PubMed    


  111. REDFORS B, Genereux P
    Response by Redfors and Genereux to Letter Regarding Article, "Stress Testing in Asymptomatic Aortic Stenosis".
    Circulation. 2017;136:1868-1869.
    PubMed    


  112. TZANIS G, Charitos C, Nanas S
    Letter by Tzanis et al Regarding Article, "Stress Testing in Asymptomatic Aortic Stenosis".
    Circulation. 2017;136:1866-1867.
    PubMed    


    October 2017
  113. CHOI B, Lee S, Chang EJ, Song JK, et al
    Response by Choi et al to Letters Regarding Article, "Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells".
    Circulation. 2017;136:1672-1673.
    PubMed    


  114. BELLIEN J, Kamel S
    Letter by Bellien and Kamel Regarding Article, "Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells".
    Circulation. 2017;136:1670-1671.
    PubMed    


  115. KOH KK
    Letter by Koh Regarding Article, "Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-Like Growth Factor-1 Signaling in Valvular Interstitial Cells".
    Circulation. 2017;136:1668-1669.
    PubMed    


  116. KAPADIA S, Tuzcu EM, Svensson LG
    Anatomy and Flow Characteristics of Neosinus: Important Consideration for Thrombosis of Transcatheter Aortic Valves.
    Circulation. 2017;136:1610-1612.
    PubMed    


  117. FUKUNAGA N, Rao V
    Letter by Fukunaga and Rao Regarding Article, "Transcatheter Treatment of Severe Tricuspid Regurgitation With the Edge-to-Edge MitraClip Technique".
    Circulation. 2017;136:1357-1358.
    PubMed    


    September 2017
  118. ROWIN EJ, Hausvater A, Link MS, Abt P, et al
    Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Circulation. 2017 Sep 15. pii: CIRCULATIONAHA.117.029267.
    PubMed     Abstract available


  119. AUFFRET V, Puri R, Urena M, Chamandi C, et al
    Conduction Disturbances After Transcatheter Aortic Valve Replacement: Current Status and Future Perspectives.
    Circulation. 2017;136:1049-1069.
    PubMed     Abstract available


  120. HYMAN MC, Vemulapalli S, Szeto WY, Stebbins A, et al
    Conscious Sedation versus General Anesthesia for Transcatheter Aortic Valve Replacement: Insights from the NCDR(R) STS/ACC TVT Registry.
    Circulation. 2017 Sep 1. pii: CIRCULATIONAHA.116.026656.
    PubMed     Abstract available


    July 2017
  121. SORAJJA P, Leon MB, Adams DH, Webb JG, et al
    Transcatheter Therapy for Mitral Regurgitation Clinical Challenges and Potential Solutions.
    Circulation. 2017;136:404-417.
    PubMed     Abstract available


  122. GLASER N, Jackson V, Holzmann MJ, Franco-Cereceda A, et al
    Prosthetic Valve Endocarditis After Surgical Aortic Valve Replacement.
    Circulation. 2017;136:329-331.
    PubMed    


    June 2017
  123. CLARK CR, Bowler MA, Snider JC, Merryman WD, et al
    Targeting Cadherin-11 Prevents Notch1-Mediated Calcific Aortic Valve Disease.
    Circulation. 2017;135:2448-2450.
    PubMed    


  124. ABDUL-JAWAD ALTISENT O, Puri R, Regueiro A, Chamandi C, et al
    Predictors and Association with Clinical Outcomes of the Changes in Exercise Capacity Following Transcatheter Aortic Valve Replacement.
    Circulation. 2017 Jun 6. pii: CIRCULATIONAHA.116.026349.
    PubMed     Abstract available


    May 2017
  125. BRANDENBURG VM, Reinartz S, Kaesler N, Kruger T, et al
    Slower Progress of Aortic Valve Calcification With Vitamin K Supplementation: Results From a Prospective Interventional Proof-of-Concept Study.
    Circulation. 2017;135:2081-2083.
    PubMed    


  126. REDFORS B, Pibarot P, Gillam LD, Burkhoff D, et al
    Stress Testing in Asymptomatic Aortic Stenosis.
    Circulation. 2017;135:1956-1976.
    PubMed     Abstract available


  127. AIKAWA E, Libby P
    A Rock and a Hard Place: Chiseling Away at the Multiple Mechanisms of Aortic Stenosis.
    Circulation. 2017;135:1951-1955.
    PubMed    



  128. Correction to: Percutaneous Therapy for Tricuspid Regurgitation: A New Frontier for Interventional Cardiology.
    Circulation. 2017;135:e1041.
    PubMed    


  129. HOLMES DR, Mack MJ
    Aortic Valve Bioprostheses: Leaflet Immobility and Valve Thrombosis.
    Circulation. 2017;135:1749-1756.
    PubMed     Abstract available


    March 2017
  130. KAPADIA SR, Krishnaswamy A, Tuzcu EM
    Percutaneous Therapy for Tricuspid Regurgitation: A New Frontier for Interventional Cardiology.
    Circulation. 2017 Mar 23. pii: CIRCULATIONAHA.116.026533.
    PubMed     Abstract available


  131. NICKENIG G, Kowalski M, Hausleiter J, Braun D, et al
    Transcatheter Treatment of Severe Tricuspid Regurgitation with the Edge-to-Edge: MitraClip Technique.
    Circulation. 2017 Mar 23. pii: CIRCULATIONAHA.116.024848.
    PubMed     Abstract available


  132. CAPOULADE R, Bowdish M, Kron IL, Smith P, et al
    Response by Capoulade et al to Letter Regarding Article, "Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty".
    Circulation. 2017;135:e785-e786.
    PubMed    


  133. POCAR M
    Letter by Pocar Regarding Article, "Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty".
    Circulation. 2017;135:e783-e784.
    PubMed    


  134. CAIRNS BJ, Coffey S, Travis RC, Prendergast B, et al
    A Replicated, Genome-Wide Significant Association of Aortic Stenosis With a Genetic Variant for Lipoprotein(a): Meta-Analysis of Published and Novel Data.
    Circulation. 2017;135:1181-1183.
    PubMed    


  135. BRIFFA N, Chambers JB
    Biological Valves in Younger Patients Undergoing Aortic Valve Replacement: A Word of Caution.
    Circulation. 2017;135:1101-1103.
    PubMed    


  136. WENDLER O, Schymik G, Treede H, Baumgartner H, et al
    SOURCE 3 Registry: Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve.
    Circulation. 2017;135:1123-1132.
    PubMed     Abstract available


  137. SHIMURA T, Yamamoto M, Kano S, Kagase A, et al
    Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement.
    Circulation. 2017 Mar 16. pii: CIRCULATIONAHA.116.025630.
    PubMed     Abstract available


  138. NISHIMURA RA, Otto CM, Bonow RO, Carabello BA, et al
    2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Circulation. 2017 Mar 15. pii: CIR.0000000000000503.
    PubMed    


    February 2017
  139. SIONTIS KC, Yao X, Gersh BJ, Noseworthy PA, et al
    Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease Other Than Significant Mitral Stenosis and Mechanical Valves: A Meta-Analysis.
    Circulation. 2017;135:714-716.
    PubMed    


  140. CHOI B, Lee S, Kim SM, Lee EJ, et al
    Dipeptidyl Peptidase-4 Induces Aortic Valve Calcification by Inhibiting Insulin-like Growth Factor-1 Signaling in Valvular Interstitial Cells.
    Circulation. 2017 Feb 8. pii: CIRCULATIONAHA.116.024270.
    PubMed     Abstract available


    January 2017
  141. PRENDERGAST BD, De Bonis M
    Valve Repair: A Durable Surgical Option in Degenerative Mitral Regurgitation.
    Circulation. 2017;135:423-425.
    PubMed    


  142. GAMMIE JS, Wilson P, Bartus K, Gackowski A, et al
    Response by Gammie et al to Letter Regarding Article, "Transapical Beating-Heart Mitral Valve Repair With an Expanded Polytetrafluoroethylene Cordal Implantation Device: Initial Clinical Experience".
    Circulation. 2017;135:e18-e19.
    PubMed    


  143. COLLI A, Gerosa G
    Letter by Colli and Gerosa Regarding Article, "Transapical Beating-Heart Mitral Valve Repair With an Expanded Polytetrafluoroethylene Cordal Implantation Device: Initial Clinical Experience".
    Circulation. 2017;135:e16-e17.
    PubMed    


  144. BERTRAND PB, Schwammenthal E, Levine RA, Vandervoort PM, et al
    Exercise Dynamics in Secondary Mitral Regurgitation: Pathophysiology and Therapeutic Implications.
    Circulation. 2017;135:297-314.
    PubMed     Abstract available


    November 2016
  145. LAZAM S, Vanoverschelde JL, Tribouilloy C, Grigioni F, et al
    Twenty-Year Outcome after Mitral Repair Versus Replacement for Severe Degenerative Mitral Regurgitation. Analysis of a Large, Prospective, Multicenter International Registry.
    Circulation. 2016 Nov 29. pii: CIRCULATIONAHA.116.023340.
    PubMed     Abstract available


  146. MARQUIS-GRAVEL G, Redfors B, Leon MB, Genereux P, et al
    Medical Treatment of Aortic Stenosis.
    Circulation. 2016;134:1766-1784.
    PubMed     Abstract available


  147. HELMS AS, Alvarado FJ, Yob J, Tang VT, et al
    Genotype-Dependent and -Independent Calcium Signaling Dysregulation in Human Hypertrophic Cardiomyopathy.
    Circulation. 2016;134:1738-1748.
    PubMed     Abstract available


  148. REYNOLDS MR, Baron SJ, Cohen DJ
    Economic Implications of Transcatheter Aortic Valve Replacement in Patients at Intermediate Surgical Risk.
    Circulation. 2016;134:1416-1418.
    PubMed    


    October 2016
  149. HADJI F, Boulanger MC, Guay SP, Gaudreault N, et al
    Altered DNA Methylation of Long Non-coding RNA H19 in Calcific Aortic Valve Disease Promotes Mineralization by Silencing NOTCH1.
    Circulation. 2016 Oct 27. pii: CIRCULATIONAHA.116.023116.
    PubMed     Abstract available


  150. MERRYMAN WD, Clark CR
    Lnc-ing NOTCH1 to Idiopathic Calcific Aortic Valve Disease.
    Circulation. 2016 Oct 27. pii: CIRCULATIONAHA.116.025601.
    PubMed     Abstract available


  151. CAPOULADE R, Zeng X, Overbey JR, Ailawadi G, et al
    Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty.
    Circulation. 2016;134:1247-1256.
    PubMed     Abstract available


  152. MASRI A, Kalahasti V, Svensson LG, Roselli EE, et al
    Aortic Cross-Sectional Area/Height Ratio and Outcomes in Patients with a Trileaflet Aortic Valve and a Dilated Aorta.
    Circulation. 2016 Oct 21. pii: CIRCULATIONAHA.116.022995.
    PubMed     Abstract available


    July 2016
  153. NGO D, Sinha S, Shen D, Kuhn EW, et al
    Aptamer-Based Proteomic Profiling Reveals Novel Candidate Biomarkers and Pathways in Cardiovascular Disease.
    Circulation. 2016;134:270-85.
    PubMed     Abstract available


    May 2016
  154. GANDHI S, Ganame J, Whitlock R, Chu V, et al
    Double Trouble: A Case of Valvular Disease in Pregnancy.
    Circulation. 2016;133:2206-11.
    PubMed    


  155. JELLIS CL, Navia JL, Flamm SD, Rodriguez LL, et al
    Severe Functional Tricuspid Stenosis Secondary to a Giant Saphenous Vein Bypass Graft Aneurysm.
    Circulation. 2016;133:2099-102.
    PubMed    


  156. HEAD SJ, Mylotte D, Mack MJ, Piazza N, et al
    Considerations and Recommendations for the Introduction of Objective Performance Criteria for Transcatheter Aortic Heart Valve Device Approval.
    Circulation. 2016;133:2086-93.
    PubMed     Abstract available


  157. MACINTYRE C, Lakdawala NK
    Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Circulation. 2016;133:1901-5.
    PubMed    


    April 2016
  158. MCELHINNEY DB, Cabalka AK, Aboulhosn JA, Eicken A, et al
    Transcatheter Tricuspid Valve-in-Valve Implantation for the Treatment of Dysfunctional Surgical Bioprosthetic Valves: An International, Multicenter Registry Study.
    Circulation. 2016;133:1582-93.
    PubMed     Abstract available


  159. VAHL TP, Hahn RT, Moses JW
    Transcatheter Valve-in-Valve Implantation for Failing Bioprosthetic Triscupid Valves: Completing the Quest.
    Circulation. 2016;133:1537-9.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: